Treatment of partial growth hormone insensitivity syndrome
CA 2187274 C · Owner: Attie, Kenneth · Inventors: Attie, Kenneth; Gesundheit, Neil; Goddard, Audrey
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods for increasing the growth rate of a human patient having partial growth hormone insensitivity syndrome but not Laron, syndrome, are described. One such method comprises administering an effective dose of growth hormone preferably growth hormone with, a native human sequence with or without an N-terminal methionine to the patient. The patient is characterized as having a height of less than about -2 standard deviations below normal for age and sex a serum level of high-affinity growth hormone binding protein that is at least a standard deviations below normal levels a serum level of IGF-I that is below normal mean levels and a serum level of growth, hormone that is at least normal. …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 24, 1995 and granted January 2, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 24, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 24, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.